News

As per the terms of the deal, Warner Chilcott assumes rights to solely promote and develop Enablex for the US. While, Novartis retains the rights to Darifenacin worldwide,

AMT-080 has shown efficacy in studies of a preclinical model of DMD. The proof of concept studies demonstrated that AMT’s technology resulted in functional dystrophin synthesis in both

The PERfECT Stent (A Prospective, Randomised Trial Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease) study compared

CHMP has further concluded that any temporary restriction on the use of Pandemrix is not considered warranted. The CHMP has recommended to continue all the ongoing analyses in

Aurobindo Pharma claims that Ampicillin & Sulbactam for injection USP is a Sterile Semi Synthetic Penicillin (SSP) product falling under the anti-infective segment and is generic equivalent to

MFSI patents include number 7,785,868, entitled ‘Apparatus to Automatically Lyse A Sample,’ which covers a set of claims describing an instrument that controls critical conditions such as temperature,

The ISO 13485:2003 quality standard is recognised as the international standard for quality management systems specific to the design, development and production of medical devices. iTech Medical president

Compare trial endpoint was major adverse cardiac events (MACE) at two years, which is a composite of all death, non-fatal heart attack (myocardial infarction or MI) and target

OmniComm provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. AE Reporting is an advanced adverse event reporting